Page 38 - Divi Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

It is turning out to be quite a stellar market after the Monday slide. How are you reading into the situation given the new Covid strain in the UK and lots of clampdowns coming in globally. It seems Indian markets are not taking too much notice? We have to realise that the vaccinations across the world will take a long time. I have been speaking to my friends and relatives in the UK but it is going very slowly and it does not look like anytime in the next 12 months we will be done with this whole drive to vaccinate the world. It will probably take the best part of two years and we are going t...

Ahead of Market: 12 things that will decide stock action on Monday SECTIONS Share Shutterstock.com As many as 200 stocks on the BSE 500 index settled the day in green, while 296 settled the day in red. NEW DELHI: Nifty formed an indecisive candle on the daily chart on Friday after it closed on a positive note for the seventh consecutive week. Shrikant Chouhan, Executive Vice President, Equity Technical Research, Kotak Securities, said, "For the next few trading sessions, 13,650 should be the sacrosanct level for the trend following traders. Above the same, we can expect an uptrend continuati...

Bull spread Strategy on Divi's Lab Buy Divi's Lab Dec 3850 Call at Rs 105 & simultaneously sell Dec 4000 Call at Rs 53 Lot Size: 200 Cost of the strategy: Rs 52 (Rs 10400 per strategy) Maximum profit: Rs 19,600 if Divi's Lab closes at or above 4,000 till 31 Dec expiry. Breakeven Point Rs 3,902 Rationale: Short covering was seen in the Divi's Lab Futures' where we have seen 1 per cent fall in the Open Interest with price rising by 3 per cent. The stock Price has broken out on the daily chart with higher volumes where it closed at all time high level. Oscillators like RSI and MFI are...

Post Market views - Dec 17, 2020 - Mr. Binod Modi, Head Strategy at Reliance Securities Posted On: 2020-12-17 05:08:59 (Time Zone: Arizona, USA) Domestic equities remained upbeat and recorded fresh highs. A dovish tone of Federal Reserve along with assurance of continuing asset purchase program until economy makes a substantial progress bolstered investors' sentiment. Financials and Pharma continued to outperform and supported market. HDFC twins, Divi's Lab and Bajaj Finance were among top gainers, while Hindalco, Asian Paints and HUL were laggards. Better prospects of earnings recovery,...

Explore Now Nifty opened positive on Thursday and continued its upward move towards a new lifetime high at the 13,773 mark. The index continued its winning streak for the fifth consecutive session and closed with a gain of more than 50 points. It formed a small bullish candle on the daily chart towards 13,850 and then 14,000 levels, while on the downside support exists at 13,500 level. India VIX slipped marginally by 0.22% from 19.20 to 19.15 level. The overall lower volatility suggests the bulls are holding a tight grip on the market and any small decline could trigger buying. On the options...